Notably, this finding is in agreement with another study which suggested that lower levels of this species at baseline were predictive of improvement in insulin sensitivity after fecal microbiota transplantation (FMT) in patients with metabolic syndrome [34]. The gene discussed is INS; the disease is metabolic syndrome.